ASO vs siRNA: RNA therapeutics with over 20 FDA approvals reviewed
EricTopol · x · 2026-09-22
Eric Topol shares a review comparing antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) and related molecular entities, which have together led to over 20 FDA approvals — with many more to come.
More from Research
- Open-source Laya classifies with calibrated probabilities in a single 33ms pass — minchoi · 2026-09-22
- Estimating Unitree G1 actuator heat loss in Isaac Sim with a physics-based model — IsaiahBallah · 2026-09-22
- Virtual Biotech teardown: 6 design decisions behind Science's 37,000-agent drug company — bravo_abad · 2026-09-22
- 37,000-agent virtual drug company: the engineering behind Virtual Biotech — bravo_abad · 2026-09-22
- LinearSolveBench debuts: testing if AI can write fast C solvers for sparse linear systems — hgarud · 2026-09-22
- Navier-Stokes partial regularity machine-checked in Lean by 50-agent swarm in 36 hours — RexDouglass · 2026-09-22